Pulmocide

Developing inhaled therapies for severe respiratory infections and lung conditions.

F-Prime Team

Sector

Life Sciences

Category

Therapeutics

Location

London, UK

Initial Investment

2013
Developing inhaled therapies for severe respiratory infections and lung conditions.

Pulmocide is a biopharmaceutical company with a mission to treat common acute and chronic respiratory tract infections associated with serious complications and devastating effects on patients’ quality of life.